nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CTSG—blood plasma—abdominal aortic aneurysm	0.043	0.158	CbGeAlD
Bortezomib—CTSG—connective tissue—abdominal aortic aneurysm	0.0229	0.0843	CbGeAlD
Bortezomib—PSMA1—connective tissue—abdominal aortic aneurysm	0.022	0.0809	CbGeAlD
Bortezomib—PSMD2—kidney—abdominal aortic aneurysm	0.0139	0.0512	CbGeAlD
Bortezomib—PSMB2—connective tissue—abdominal aortic aneurysm	0.0123	0.045	CbGeAlD
Bortezomib—PSMD1—spinal cord—abdominal aortic aneurysm	0.0122	0.045	CbGeAlD
Bortezomib—PSMD2—spinal cord—abdominal aortic aneurysm	0.0108	0.0399	CbGeAlD
Bortezomib—PSMB1—kidney—abdominal aortic aneurysm	0.0107	0.0393	CbGeAlD
Bortezomib—PSMB2—kidney—abdominal aortic aneurysm	0.0104	0.0383	CbGeAlD
Bortezomib—PSMB5—spinal cord—abdominal aortic aneurysm	0.00952	0.035	CbGeAlD
Bortezomib—SLC31A1—kidney—abdominal aortic aneurysm	0.00903	0.0332	CbGeAlD
Bortezomib—CYP2C19—blood plasma—abdominal aortic aneurysm	0.0084	0.0309	CbGeAlD
Bortezomib—PSMB1—spinal cord—abdominal aortic aneurysm	0.00832	0.0306	CbGeAlD
Bortezomib—PSMB2—spinal cord—abdominal aortic aneurysm	0.00812	0.0299	CbGeAlD
Bortezomib—PTGS1—artery—abdominal aortic aneurysm	0.00793	0.0291	CbGeAlD
Bortezomib—CYP2C8—blood plasma—abdominal aortic aneurysm	0.00733	0.027	CbGeAlD
Bortezomib—SLC31A1—spinal cord—abdominal aortic aneurysm	0.00703	0.0259	CbGeAlD
Bortezomib—CYP1A2—blood plasma—abdominal aortic aneurysm	0.00686	0.0252	CbGeAlD
Bortezomib—CYP2C9—blood plasma—abdominal aortic aneurysm	0.00651	0.0239	CbGeAlD
Bortezomib—PTGS1—blood plasma—abdominal aortic aneurysm	0.00595	0.0219	CbGeAlD
Bortezomib—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00497	0.0183	CbGeAlD
Bortezomib—CYP2D6—blood plasma—abdominal aortic aneurysm	0.00489	0.018	CbGeAlD
Bortezomib—CYP2C8—kidney—abdominal aortic aneurysm	0.00332	0.0122	CbGeAlD
Bortezomib—PTGS1—connective tissue—abdominal aortic aneurysm	0.00317	0.0116	CbGeAlD
Bortezomib—CYP1A1—kidney—abdominal aortic aneurysm	0.00307	0.0113	CbGeAlD
Bortezomib—PTGS1—kidney—abdominal aortic aneurysm	0.0027	0.00991	CbGeAlD
Bortezomib—CYP3A4—kidney—abdominal aortic aneurysm	0.00225	0.00828	CbGeAlD
Bortezomib—CYP2D6—kidney—abdominal aortic aneurysm	0.00222	0.00814	CbGeAlD
Bortezomib—PTGS1—spinal cord—abdominal aortic aneurysm	0.0021	0.00772	CbGeAlD
Bortezomib—PSMD2—Metabolism—LDLR—abdominal aortic aneurysm	0.000577	0.000793	CbGpPWpGaD
Bortezomib—PSMA1—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.000575	0.00079	CbGpPWpGaD
Bortezomib—PSMD1—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.000573	0.000787	CbGpPWpGaD
Bortezomib—PSMD2—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.00057	0.000783	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—abdominal aortic aneurysm	0.000536	0.000737	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—NCF1—abdominal aortic aneurysm	0.000534	0.000734	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—NCF1—abdominal aortic aneurysm	0.000534	0.000734	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—NCF1—abdominal aortic aneurysm	0.000534	0.000734	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—NFKB1—abdominal aortic aneurysm	0.000531	0.000729	CbGpPWpGaD
Bortezomib—PSMB2—Disease—LDLR—abdominal aortic aneurysm	0.000527	0.000724	CbGpPWpGaD
Bortezomib—PSMB5—Disease—LDLR—abdominal aortic aneurysm	0.000527	0.000724	CbGpPWpGaD
Bortezomib—PSMB1—Disease—LDLR—abdominal aortic aneurysm	0.000527	0.000724	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—NCF1—abdominal aortic aneurysm	0.000526	0.000723	CbGpPWpGaD
Bortezomib—PSMB8—Disease—LDLR—abdominal aortic aneurysm	0.00052	0.000714	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000518	0.000712	CbGpPWpGaD
Bortezomib—PSMA1—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.000515	0.000707	CbGpPWpGaD
Bortezomib—PSMD1—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.000512	0.000703	CbGpPWpGaD
Bortezomib—PSMD2—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.00051	0.0007	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—AAAS—abdominal aortic aneurysm	0.000506	0.000695	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—AAAS—abdominal aortic aneurysm	0.000506	0.000695	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—AAAS—abdominal aortic aneurysm	0.000506	0.000695	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—AAAS—abdominal aortic aneurysm	0.000499	0.000685	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NCF1—abdominal aortic aneurysm	0.000493	0.000677	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NCF1—abdominal aortic aneurysm	0.000493	0.000677	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NCF1—abdominal aortic aneurysm	0.000493	0.000677	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000487	0.000669	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000487	0.000669	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000487	0.000669	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000487	0.000669	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NCF1—abdominal aortic aneurysm	0.000486	0.000668	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000485	0.000666	CbGpPWpGaD
Bortezomib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—abdominal aortic aneurysm	0.000485	0.000666	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000482	0.000663	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.00048	0.00066	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000456	0.000626	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000456	0.000626	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000456	0.000626	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000456	0.000626	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000453	0.000623	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000451	0.00062	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000449	0.000617	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—LDLR—abdominal aortic aneurysm	0.000441	0.000606	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—LDLR—abdominal aortic aneurysm	0.000441	0.000606	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—LDLR—abdominal aortic aneurysm	0.000441	0.000606	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.000436	0.000599	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.000436	0.000599	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.000436	0.000599	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—LDLR—abdominal aortic aneurysm	0.000435	0.000598	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle, Mitotic—CDKN2A—abdominal aortic aneurysm	0.00043	0.000591	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.00039	0.000536	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.00039	0.000536	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.00039	0.000536	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle—CDKN2A—abdominal aortic aneurysm	0.000384	0.000528	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000382	0.000525	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000381	0.000523	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000379	0.00052	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000369	0.000507	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000369	0.000507	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000369	0.000507	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000366	0.000503	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000365	0.000502	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000364	0.0005	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.000364	0.0005	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000362	0.000498	CbGpPWpGaD
Bortezomib—PSMA1—Disease—APOE—abdominal aortic aneurysm	0.00036	0.000495	CbGpPWpGaD
Bortezomib—PSMD1—Disease—APOE—abdominal aortic aneurysm	0.000358	0.000492	CbGpPWpGaD
Bortezomib—PSMD2—Disease—APOE—abdominal aortic aneurysm	0.000357	0.00049	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000345	0.000474	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000345	0.000474	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000345	0.000474	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.00034	0.000468	CbGpPWpGaD
Bortezomib—PSMA1—Disease—NOS2—abdominal aortic aneurysm	0.000336	0.000461	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000335	0.00046	CbGpPWpGaD
Bortezomib—PSMD1—Disease—NOS2—abdominal aortic aneurysm	0.000334	0.000459	CbGpPWpGaD
Bortezomib—PSMD2—Disease—NOS2—abdominal aortic aneurysm	0.000332	0.000457	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000326	0.000448	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000324	0.000446	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000323	0.000444	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—AGT—abdominal aortic aneurysm	0.000308	0.000423	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—AGT—abdominal aortic aneurysm	0.000306	0.000421	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—AGT—abdominal aortic aneurysm	0.000305	0.000419	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000304	0.000418	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000303	0.000416	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—APOE—abdominal aortic aneurysm	0.000302	0.000414	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000302	0.000414	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—APOE—abdominal aortic aneurysm	0.0003	0.000412	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—APOE—abdominal aortic aneurysm	0.000299	0.00041	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000299	0.00041	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.00029	0.000398	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.00029	0.000398	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.00029	0.000398	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—NFKB1—abdominal aortic aneurysm	0.000286	0.000393	CbGpPWpGaD
Bortezomib—PSMA1—Disease—SERPINE1—abdominal aortic aneurysm	0.000283	0.000388	CbGpPWpGaD
Bortezomib—PSMD1—Disease—SERPINE1—abdominal aortic aneurysm	0.000281	0.000386	CbGpPWpGaD
Bortezomib—PSMD2—Disease—SERPINE1—abdominal aortic aneurysm	0.00028	0.000385	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000277	0.000381	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000277	0.000381	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000277	0.000381	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000274	0.000376	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000273	0.000375	CbGpPWpGaD
Bortezomib—PSMB1—Disease—APOE—abdominal aortic aneurysm	0.000273	0.000375	CbGpPWpGaD
Bortezomib—PSMB5—Disease—APOE—abdominal aortic aneurysm	0.000273	0.000375	CbGpPWpGaD
Bortezomib—PSMB2—Disease—APOE—abdominal aortic aneurysm	0.000273	0.000375	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000272	0.000374	CbGpPWpGaD
Bortezomib—PSMB8—Disease—APOE—abdominal aortic aneurysm	0.000269	0.00037	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000268	0.000369	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—AAAS—abdominal aortic aneurysm	0.000264	0.000363	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000257	0.000354	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000256	0.000352	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000255	0.00035	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NOS2—abdominal aortic aneurysm	0.000254	0.000349	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NOS2—abdominal aortic aneurysm	0.000254	0.000349	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NOS2—abdominal aortic aneurysm	0.000254	0.000349	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000252	0.000346	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000251	0.000345	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NOS2—abdominal aortic aneurysm	0.000251	0.000344	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.00025	0.000343	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000247	0.000339	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000247	0.000339	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000247	0.000339	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PTGS2—abdominal aortic aneurysm	0.000247	0.000339	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PTGS2—abdominal aortic aneurysm	0.000246	0.000337	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PTGS2—abdominal aortic aneurysm	0.000244	0.000336	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000244	0.000335	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—AGT—abdominal aortic aneurysm	0.000233	0.00032	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—AGT—abdominal aortic aneurysm	0.000233	0.00032	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—AGT—abdominal aortic aneurysm	0.000233	0.00032	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000233	0.00032	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—NFKB1—abdominal aortic aneurysm	0.000232	0.000319	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—NFKB1—abdominal aortic aneurysm	0.000231	0.000317	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—LDLR—abdominal aortic aneurysm	0.000231	0.000317	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000231	0.000317	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000231	0.000317	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000231	0.000317	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—AGT—abdominal aortic aneurysm	0.00023	0.000316	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—NFKB1—abdominal aortic aneurysm	0.00023	0.000316	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—APOE—abdominal aortic aneurysm	0.000229	0.000314	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—APOE—abdominal aortic aneurysm	0.000229	0.000314	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—APOE—abdominal aortic aneurysm	0.000229	0.000314	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—SERPINE1—abdominal aortic aneurysm	0.000227	0.000312	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—APOE—abdominal aortic aneurysm	0.000225	0.00031	CbGpPWpGaD
Bortezomib—PSMB1—Disease—SERPINE1—abdominal aortic aneurysm	0.000214	0.000294	CbGpPWpGaD
Bortezomib—PSMB5—Disease—SERPINE1—abdominal aortic aneurysm	0.000214	0.000294	CbGpPWpGaD
Bortezomib—PSMB2—Disease—SERPINE1—abdominal aortic aneurysm	0.000214	0.000294	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000212	0.000291	CbGpPWpGaD
Bortezomib—PSMB8—Disease—SERPINE1—abdominal aortic aneurysm	0.000211	0.00029	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000211	0.00029	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.00021	0.000288	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000207	0.000284	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000206	0.000283	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000205	0.000281	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000198	0.000272	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000197	0.000271	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000196	0.000269	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000195	0.000268	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000195	0.000268	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000195	0.000268	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000193	0.000265	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000192	0.000264	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000191	0.000263	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000191	0.000263	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000191	0.000263	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000189	0.00026	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000188	0.000259	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PTGS2—abdominal aortic aneurysm	0.000187	0.000257	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PTGS2—abdominal aortic aneurysm	0.000187	0.000257	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PTGS2—abdominal aortic aneurysm	0.000187	0.000257	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AAAS—abdominal aortic aneurysm	0.000186	0.000256	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PTGS2—abdominal aortic aneurysm	0.000184	0.000253	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000184	0.000253	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000177	0.000243	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—NFKB1—abdominal aortic aneurysm	0.000176	0.000242	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—NFKB1—abdominal aortic aneurysm	0.000176	0.000242	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—NFKB1—abdominal aortic aneurysm	0.000176	0.000242	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—NFKB1—abdominal aortic aneurysm	0.000173	0.000238	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000173	0.000238	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AAAS—abdominal aortic aneurysm	0.000171	0.000235	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—LDLR—abdominal aortic aneurysm	0.000163	0.000223	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000161	0.000221	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000161	0.000221	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000161	0.000221	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CCL2—abdominal aortic aneurysm	0.000158	0.000218	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000158	0.000217	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTGS2—abdominal aortic aneurysm	0.000157	0.000215	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTGS2—abdominal aortic aneurysm	0.000157	0.000215	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTGS2—abdominal aortic aneurysm	0.000157	0.000215	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000155	0.000213	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTGS2—abdominal aortic aneurysm	0.000154	0.000212	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AAAS—abdominal aortic aneurysm	0.000152	0.000209	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000152	0.000208	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000151	0.000207	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.00015	0.000206	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.00015	0.000206	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00015	0.000206	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00015	0.000206	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.00015	0.000206	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000149	0.000205	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—LDLR—abdominal aortic aneurysm	0.000149	0.000205	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000149	0.000204	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	0.000148	0.000203	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000144	0.000198	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000141	0.000194	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AAAS—abdominal aortic aneurysm	0.00014	0.000193	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AAAS—abdominal aortic aneurysm	0.000139	0.000191	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—LDLR—abdominal aortic aneurysm	0.000133	0.000183	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.00013	0.000178	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000123	0.000169	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—LDLR—abdominal aortic aneurysm	0.000122	0.000168	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—AGT—abdominal aortic aneurysm	0.000122	0.000168	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LDLR—abdominal aortic aneurysm	0.000121	0.000167	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000121	0.000166	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—APOE—abdominal aortic aneurysm	0.00012	0.000164	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000119	0.000163	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AAAS—abdominal aortic aneurysm	0.000119	0.000163	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000115	0.000158	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000115	0.000158	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000115	0.000158	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000114	0.000156	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000114	0.000156	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000114	0.000156	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP9—abdominal aortic aneurysm	0.000113	0.000156	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NFKB1—abdominal aortic aneurysm	0.000112	0.000154	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000106	0.000146	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LDLR—abdominal aortic aneurysm	0.000104	0.000142	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	9.67e-05	0.000133	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	9.17e-05	0.000126	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—AGT—abdominal aortic aneurysm	8.59e-05	0.000118	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOE—abdominal aortic aneurysm	8.42e-05	0.000116	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	8.26e-05	0.000113	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—abdominal aortic aneurysm	8.19e-05	0.000112	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	8e-05	0.00011	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—AGT—abdominal aortic aneurysm	7.88e-05	0.000108	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOE—abdominal aortic aneurysm	7.72e-05	0.000106	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—AGT—abdominal aortic aneurysm	7.03e-05	9.66e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOE—abdominal aortic aneurysm	6.89e-05	9.47e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—AGT—abdominal aortic aneurysm	6.47e-05	8.89e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—AGT—abdominal aortic aneurysm	6.41e-05	8.81e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOE—abdominal aortic aneurysm	6.34e-05	8.71e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOE—abdominal aortic aneurysm	6.28e-05	8.63e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—abdominal aortic aneurysm	5.77e-05	7.93e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—AGT—abdominal aortic aneurysm	5.48e-05	7.53e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOE—abdominal aortic aneurysm	5.37e-05	7.38e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—abdominal aortic aneurysm	5.29e-05	7.27e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—abdominal aortic aneurysm	4.72e-05	6.49e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—abdominal aortic aneurysm	4.34e-05	5.97e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—abdominal aortic aneurysm	4.31e-05	5.91e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	4.23e-05	5.81e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	4.14e-05	5.69e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—abdominal aortic aneurysm	3.68e-05	5.05e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	2.84e-05	3.9e-05	CbGpPWpGaD
